scispace - formally typeset
J

Jawaid Akhtar

Researcher at National University of Science and Technology

Publications -  19
Citations -  713

Jawaid Akhtar is an academic researcher from National University of Science and Technology. The author has contributed to research in topics: Docking (molecular) & Benzimidazole. The author has an hindex of 9, co-authored 19 publications receiving 395 citations. Previous affiliations of Jawaid Akhtar include Jamia Hamdard & Hamdard University.

Papers
More filters
Journal ArticleDOI

Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.

TL;DR: The present review article offers a detailed account of the design strategies employed for the synthesis of nitrogen-containing anticancer agents and a systematic analysis of the structure-activity relationship among the series.
Journal ArticleDOI

Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors

TL;DR: The synthesis of benzimidazole linked oxadiazole derivatives designed as potential EGFR and erbB2 receptor inhibitors with anticancer and apoptotic activity were studied and compounds 7a and 7n showed normal architecture of myofibrils in cardiomyopathy study whereas only compound 7a showed nearly equal biochemical parameters when compared to control.
Journal ArticleDOI

Current perspectives on quinazolines with potent biological activities: A review

TL;DR: Quinazoline is a heterocyclic compound having biological activities as discussed by the authors, it is aromatic in nature having bicyclic structure containing benzene ring and pyrimidine ring.
Journal ArticleDOI

Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship

TL;DR: Design strategies for the synthesis of isatin containing heterocyclic through their different approaches have been represented and structural insights and important account of structure-activity relationships and docking studies of isarin derivatives for the potent pharmacological profile are provided.
Journal ArticleDOI

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.

TL;DR: This review focuses on the current status of the research and contributions in the development of DYRK1A inhibitors, a potential target for prevention of neuro-degeneration and hence Alzheimer.